Resolute italian study in all comers: Immediate and One-Year Outcomes

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 4, 2012, Pages 567-574

  Romagnoli, Enrico ^a   Godino, Cosmo ^b   Ielasi, Alfonso ^b   Gasparini, Gabriele ^c   Tzifos, Vaios ^d   Sciahbasi, Alessandro ^a   Lioy, Ernesto ^a   Presbitero, Patrizia ^c   Colombo, Antonio ^b   Sangiorgi, Giuseppe ^e  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b EMO GVM CENTRO CUORE COLUMBUS   (Italy)

^c Scientific Institute Humanitas   (Italy)

^d HENRY DUNANT HOSPITAL   (Greece)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

coronary angioplasty; multicenter registry; zotarolimus drug eluting stent

Indexed keywords

ZOTAROLIMUS;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART DEATH; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; IMPLANT REGISTRY; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OFF LABEL DRUG USE; REVASCULARIZATION; STENT THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DRUG-ELUTING STENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; PRODUCT LABELING; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857457407     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23046     Document Type: Article

References (21)

1. Cook S, Ladich E, Nakazawa G, Eshtehardi P, Neidhart M, Vogel R, Togni M, Wenaweser P, Billinger M, Seiler C, Gay S, Meier B, Pichler WJ, Jüni P, Virmani R, Windecker S,. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009; 120: 391-399.
2. Joner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R,. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol 2008; 52: 333-342. (Pubitemid 352001347)
3. Udipi K, Melder RJ, Chen M, Cheng P, Hezi-Yamit A, Sullivan C, Wong J, Wilcox J,. The next generation endeavor resolute stent: Role of the BioLinx polymer system. EuroIntervention 2007; 3: 137-139.
4. Waseda K, Ako J, Yamasaki M, Koizumi T, Ormiston J, Worthley SG, Whitbourn RJ, Walters DL, Honda Y, Meredith IT, Fitzgerald PJ,; RESOLUTE Trial Investigators. Short- and mid-term intravascular ultrasound analysis of the new zotarolimus-eluting stent with durable polymer-Results from the RESOLUTE trial. Circ J 2010; 74: 2097-2102.
5. Meredith IT, Worthley S, Whitbourn R, Walters D, Popma J, Cutlip D, Fitzgerald P,. The next-generation Endeavor Resolute stent: 4-month clinical and angiographic results from the Endeavor Resolute first-in-man trial. EuroIntervention 2007; 3: 50-53.
6. Meredith IT, Worthley S, Whitbourn R, Walters DL, McClean D, Horrigan M, Popma JJ, Cutlip DE, DePaoli A, Negoita M, Fitzgerald PJ,; RESOLUTE Investigators. Clinical and angiographic results with the next-generation resolute stent system: A prospective, multicenter, first-in-human trial. JACC Cardiovasc Interv. 2009; 2: 977-985.
7. Meredith IT, Worthley SG, Whitbourn R, Walters D, McClean D, Ormiston J, Horrigan M, Wilkins GT, Hendriks R, Matsis P, Muller D, Cutlip DE,. Long-term clinical outcomes with the next generation resolute stent system: A report of the two-year follow-up from the RESOLUTE clinical trial. EuroIntervention 2010; 5: 692-697.
8. Serruys PW, Silber S, Garg S, van Geuns RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH, Linke A, Klauss V, Wijns W, Macaya C, Garot P, DiMario C, Manoharan G, Kornowski R, Ischinger T, Bartorelli A, Ronden J, Bressers M, Gobbens P, Negoita M, van Leeuwen F, Windecker S, Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med 2010; 363: 136-146.
9. Qasim A, Cosgrave J, Latib A, Colombo A,. Long-term follow-up of drug-eluting stents when inserted for on- and off-label indications. Am J Cardiol 2007; 100: 1619-1624. (Pubitemid 350122326)
10. Roy P, Buch AN, Javaid A, Okabe T, Raya V, Pinto Slottow TL, Steinberg DH, Smith K, Xue Z, Gevorkian N, Satler LF, Kent KM, Suddath WO, Pichard AD, Lindsay J, Waksman R,. Impact of "off-label" utilization of drug-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention. Am J Cardiol 2008; 101: 293-299. (Pubitemid 351162956)
11. Ko DT, Chiu M, Guo H, Austin PC, Goeree R, Cohen E, Labinaz M, Tu JV,. Safety and effectiveness of drug-eluting and bare-metal stents for patients with off- and on-label indications. J Am Coll Cardiol 2009; 53: 1773-1782.
12. Carlsson J, James SK, Lindbäck J, Scherstén F, Nilsson T, Stenestrand U, Lagerqvist B,; SCAAR (Swedish Coronary Angiography and Angioplasty Registry) Study Group. Outcome of drug-eluting versus bare-metal stenting used according to on- and off-label criteria. J Am Coll Cardiol 2009; 53: 1389-1398.
13. Austin D, Oldroyd KG, McConnachie A, Slack R, Eteiba H, Flapan AD, Jennings KP, Northcote RJ, Pell AC, Starkey IR, Pell JP,. Drug-eluting stents versus bare-metal stents for off-label indications: A propensity score-matched outcome study. Circ Cardiovasc Interv 2008; 1: 45-52.
14. Latib A, Ferri L, Ielasi A, Godino C, Chieffo A, Magni V, Bassanelli G, Sharp AS, Gerber R, Michev I, Carlino M, Airoldi F, Sangiorgi GM, Montorfano M, Colombo A, Clinical outcomes after unrestricted implantation of everolimus-eluting stents. JACC Cardiovasc Interv 2009; 2: 1219-1226.
15. Räber L, Jüni P, Löffel L, Wandel S, Cook S, Wenaweser P, Togni M, Vogel R, Seiler C, Eberli F, Lüscher T, Meier B, Windecker S,. Impact of stent overlap on angiographic and long-term clinical outcome in patients undergoing drug-eluting stent implantation. J Am Coll Cardiol 2010; 55: 1178-1188.
16. Sharp AS, Latib A, Ielasi A, Larosa C, Godino C, Saolini M, Magni V, Gerber RT, Montorfano M, Carlino M, Michev I, Chieffo A, Colombo A,. Long-term follow-up on a large cohort of "full-metal jacket" percutaneous coronary intervention procedures. Circ Cardiovasc Interv 2009; 2: 416-422.
17. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW,; Academic Research Consortium. Clinical end points in coronary stent trials: A case for standardized definitions. Circulation 2007; 115: 2344-2351. (Pubitemid 46685903)
18. Thygesen K, Alpert JS, White HD,. Joint ESC/ACCF/AHA/WHF task force for the redefinition of myocardial infarction. Universal definition of myocardial infarction. Circulation 2007; 116: 2634-2653.
19. Anderson JR, Cain KC, Gelber RD,. Analysis of survival by tumor response. J Clin Oncol 1983; 1: 710-719. (Pubitemid 14202071)
20. Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE,; ENDEAVOR II Investigators. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine encapsulated stent for treatment of native coronary artery lesions: Clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006; 114: 798-806. (Pubitemid 44268230)
21. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Mahaffey KW, Cutlip DE, Fitzgerald PJ, Sood P, Su X, Lansky AJ,; SPIRIT III Investigators. Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA 2008; 299: 1903-1913. (Pubitemid 351574920)